Vaxart, Inc. (VXRT): EPS (Diluted)

Annual figures by period end, from SEC filings.

$0.07
Year ended 2025-12-31
2011-06-30: -$1.122012-06-30: -$0.852013-06-30: -$0.322014-06-30: -$0.352015-06-30: -$0.542016-06-30: -$0.662017-06-30: -$0.762024-12-31: -$0.332025-12-31: $0.07$0.07
2011-06-30 EPS (Diluted) (USD per share) 2025-12-31
Period endedEPS (Diluted)Change YoYSource filing
2025-12-31$0.07n/m2026-03-13, From 2025-01-01
2024-12-31-$0.33n/a2026-03-13, From 2024-01-01
No annual figure between 2017-06-30 and 2024-12-31.
2017-06-30-$0.76n/m2017-09-01, From 2016-07-01
2016-06-30-$0.66n/m2017-09-01, From 2015-07-01
2015-06-30-$0.54n/m2016-09-13, From 2014-07-01
2014-06-30-$0.35n/m2016-09-13, From 2013-07-01
2013-06-30-$0.32n/m2015-09-11, From 2012-07-01
2012-06-30-$0.85n/m2013-09-27, From 2011-07-01
2011-06-30-$1.12n/a2013-09-27, From 2010-07-01

EPS (Diluted) at similar companies

Companies with the same SEC industry code (Biological Products, (No Diagnostic Substances)), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEPS (Diluted)Change YoY
Vaxart, Inc. (VXRT)2025-12-31$0.07n/m
Iovance Biotherapeutics, Inc. (IOVA)2025-12-31-$1.09n/m
Vericel Corp (VCEL)2025-12-31$0.32+60.0%
Adaptive Biotechnologies Corp (ADPT)2025-12-31-$0.39n/m
Adaptimmune Therapeutics PLC (ADAPY)2024-12-31-$0.05n/m
REGENXBIO Inc. (RGNX)2025-12-31-$3.76n/m
Ginkgo Bioworks Holdings, Inc. (DNA)2025-12-31-$5.64n/m
Twist Bioscience Corp (TWST)2025-09-30-$1.30n/m
Krystal Biotech, Inc. (KRYS)2025-12-31$6.84+128.0%

Compare VXRT, IOVA, VCEL, ADPT side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗